Rebuilding brain pathways to improve motor function in Parkinson's disease
Tissue Engineered Nigrostriatal Pathway for Anatomical Tract Reconstruction in Parkinson's Disease
This study is exploring a new way to help people with Parkinson's disease by creating special pathways in the brain using human stem cells, which could improve movement better than current treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10915583 on NIH RePORTER |
What this research studies
This research investigates a novel approach to treating Parkinson's disease by reconstructing the nigrostriatal pathway, which is crucial for motor function. The team will create tissue-engineered pathways using human stem cell-derived dopaminergic neurons and their axonal fibers, encased in a biocompatible hydrogel. These engineered pathways will be implanted to restore the anatomical connections in the brain, aiming to enhance motor function compared to traditional therapies. The research will be conducted using a rat model to evaluate the effectiveness of this innovative treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease who are experiencing motor function decline.
Not a fit: Patients with advanced Parkinson's disease or those who have other neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant improvements in motor function for patients with Parkinson's disease.
How similar studies have performed: While similar approaches have been explored, this specific method of pathway reconstruction using tissue-engineered solutions is relatively novel and has not been extensively tested.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Cullen, Daniel Kacy — University of Pennsylvania
- Study coordinator: Cullen, Daniel Kacy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.